Immunosuppression Associated With Novel Chemotherapy Agents and Monoclonal Antibodies

Herpes zoster complicating bortezomib therapy of relapsed/refractory indolent B-cell and mantle cell lymphoma: an analysis of two phase II trials

(2013) Melhem Solh et al.   LEUKEMIA & LYMPHOMA

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry

(2012) Lene Dreyer et al.   ANNALS OF THE RHEUMATIC DISEASES

Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

(2012) Sotirios Tsiodras et al.   MAYO CLINIC PROCEEDINGS

Hepatitis B virus management to prevent reactivation after chemotherapy: a review

(2012) Jessica P. Hwang et al.   SUPPORTIVE CARE IN CANCER

Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

(2012) Jeffrey R. Curtis et al.   ARTHRITIS CARE & RESEARCH

Tuberculosis and other infections in the anti-tumour necrosis factor-alpha (anti-TNF-α) era

(2011) Francesca Nacci et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies

(2011) E. Tavazzi et al.   CLINICAL MICROBIOLOGY AND INFECTION

Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases

(2011) Andrea T. Borchers et al.   JOURNAL OF AUTOIMMUNITY

Current trends in management of hepatitis B virus reactivation in the biologic therapy era

(2011) Claudio M Mastroianni   WORLD JOURNAL OF GASTROENTEROLOGY

Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches

(2010) Vicki A. Morrison   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101

(2010) Thomas S. Lin et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

(2009) Anja Strangfeld   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901

(2009) John C. Byrd et al.   LEUKEMIA & LYMPHOMA

Analysis of Herpes Zoster Events Among Bortezomib-Treated Patients in the Phase III APEX Study

(2008) Asher Chanan-Khan et al.   JOURNAL OF CLINICAL ONCOLOGY